ClinicalTrials.gg
Status unknownNCT06318351Updated Apr 9, 2024

Transcutaneous Acupoint Electrical Stimulation and Postoperative Delirium Delirium

An observational study in Delirium, Postoperative, sponsored by Qin Zhang. Status unknown at 2 sites in China. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2024-04-09.

Sponsored by Qin Zhang · Observational

The sponsor has not verified this record recently (last verified Apr 2024), so the status shown — last known as Recruiting — may be out of date.
Study type
Observational
Model
Cohort
Time perspective
Prospective
Enrollment
476
Ages
18 Years and older
Sex
All
01

Study summary

Investigating postoperative delirium in patients undergoing thoracoscopic lung resection surgery who have received or not received relevant transcutaneous acupoint electrical stimulation treatment preoperatively, observing postoperative recovery quality indicators, evaluating the necessity of treatment, and clarifying the potential mechanisms by which transcutaneous acupoint electrical stimulation may improve postoperative delirium.

Read the detailed description

Research design type: multicenter, prospective, cohort observational trial. The leading unit is Tongji Hospital affiliated with Tongji Medical College of Huazhong University of Science and Technology, and the participating unit is Guangdong Provincial Hospital of Chinese Medicine (a large comprehensive traditional Chinese medicine hospital directly under the National Administration of Traditional Chinese Medicine), skilled in using traditional Chinese medicine treatment methods to improve postoperative recovery quality. Participating in a multicenter clinical study on transcutaneous acupoint electrical stimulation to improve postoperative delirium after thoracoscopic surgery will help collectively explore the perioperative application and mechanism of action of traditional Chinese medicine techniques for acupoint stimulation.

Firstly, patients meeting the inclusion criteria from the Department of Thoracic Surgery of Tongji Hospital affiliated with Tongji Medical College of Huazhong University of Science and Technology and Guangdong Provincial Hospital of Chinese Medicine will be recruited. Upon admission, the Mini-Mental State Examination (MMSE) will be used as a routine clinical assessment to screen all patients for cognitive status to reduce the impact of cognitive impairments on subsequent observations. Subsequently, based on whether patients receive transcutaneous acupoint electrical stimulation treatment by an anesthesiologist, patients will be divided into two groups (yes or no for receiving the treatment). Their recovery period, delirium assessment within 7 days postoperatively, as well as assessments of sleep, pain, etc., will be observed. Preoperative and postoperative peripheral blood samples will be collected for testing related indicators. Information on demographic characteristics, discharge diagnosis, laboratory indicators at admission and discharge, postoperative complications, length of hospital stay, disease awareness, etc., will be collected from the medical records system for statistical analysis to explore the correlation between transcutaneous acupoint electrical stimulation and postoperative delirium in patients undergoing thoracoscopic lung resection.

02

Conditions studied

  • Delirium, Postoperative

Keywords

  • Delirium
  • Thoracoscopic lung resection surgery
03

In context

Emergence Delirium

788 studies on the registry are indexed under Emergence Delirium; 250 are open to participants now.

This study's planned enrollment of 476 is above the median of 154 across 288 observational studies indexed under Emergence Delirium.

Browse Emergence Delirium studies →

Lead sponsor

Qin Zhang is the lead sponsor of 14 studies on the registry; 3 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years and older
Sexes eligible
All
Sampling method
Probability sample

Study population

Patients undergoing thoracoscopic pneumonectomy

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  1. Voluntary participation in the study;
  2. Age ≥ 18 years;
  3. Patients scheduled for thoracoscopic lung resection surgery;
  4. ASA grade I-III.

Exclusion criteria

Exclusion Criteria:

  1. History of severe central nervous system diseases, psychiatric disorders, cognitive impairment, intellectual disability, or Mini-Mental State Examination (MMSE) score ≤23;
  2. History of opioid addiction, long-term use of analgesic drugs, or psychotropic drugs;
  3. Severe cardiovascular and cerebrovascular diseases;
  4. Severe liver and kidney dysfunction: Child-Pugh grade B, C patients, patients requiring regular dialysis, etc.;
  5. Pregnant or postpartum women;
  6. Patients with language communication barriers;
  7. Deemed unsuitable for participation by the researchers.
05

Study design

Observational model
Cohort
Time perspective
Prospective
Enrollment
476 participants (estimated)
Target follow-up
7 Days
Patient registry
Yes
Biospecimen retention
Samples without dna

Groups and cohorts

  • Transcutaneous Electrical Acupoint Stimulation

    The effect of Transcutaneous Electrical Acupoint Stimulation on postoperative vision was observed according to anesthesiologist's habit of using or not using it.

    Procedure: transcutaneous acupoint electrical stimulation

Interventions

  • Proceduretranscutaneous acupoint electrical stimulation

    This is a safe and non-invasive procedure, similar to an electrode sheet, which applies a weak current to a specific site to achieve the purpose of acupoint stimulation.

06

What researchers measure

Primary outcomes

  1. Delirium

    Mini-Mental State Examination, MMSE

    Time frame: 7days

Secondary outcomes

  1. Recovery

    Questionnaire

    Time frame: 7days

07

Study locations

1 of 2 sites recruiting
  • Guangdong Hospital of Traditional Chinese Medicine
    Guangzhou, Guangdong 510000, China
    Not yet recruiting
  • Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology
    Wuhan, Hubei 430030, China
    Recruiting
08

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Apr 9, 2024, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
09

Registry details

Key details

Study ID
NCT06318351
Lead sponsor
Qin Zhang
Collaborators
National Natural Science Foundation of China
Responsible party
Qin Zhang (Professor, Tongji Hospital) — Sponsor-investigator
First posted
Mar 19, 2024
Start date
Feb 1, 2024
Primary completion
Dec 30, 2024 (estimated)
Completion
Aug 30, 2025 (estimated)
Last update
Apr 9, 2024

Study contacts

Xiao Ran, phd
Contact
ranxiao1001@tjh.tjmu.edu.cn
15926207366
Qin Zhang, phd
principal investigator · Tongji Medical College, Huazhong University of Science and Technology

Oversight

Data monitoring committee
Yes
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is status unknown, as verified in Apr 2024. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion